articleTop 1% cited

Efficacy and tolerability of doxazosin and finasteride, alone or in combination, in treatment of symptomatic benign prostatic hyperplasia: the Prospective European Doxazosin and Combination Therapy (PREDICT) trial

Urology · 2003 · Vol. 61(1) · pp. 119–126

Roger Kirby✉(St George's Hospital)Claus G. RoehrbornPeter Boyle(European Institute of Oncology)Georg Bartsch(Universität Innsbruck)A Jardin(Bicêtre Hospital)Margaret M Cary(Pfizer (United States))Michael Sweeney(Pfizer (United States))Eric Grossman(Pfizer (United States))

View via DOI Publisher page

Urinary Bladder and Prostate Research Hormonal and reproductive studies Prostate Cancer Diagnosis and TreatmentDoxazosinFinasterideMedicineUrologyTolerabilityPlaceboLower urinary tract symptomsHyperplasiaCombination therapyInternational Prostate Symptom Score

MeSH terms

Adrenergic alpha-AntagonistsAgedDiuresisDouble-Blind MethodDrug Administration ScheduleDrug Therapy, CombinationEnzyme InhibitorsHumansMaleMiddle AgedProspective StudiesProstatic HyperplasiaPlacebo EffectTreatment OutcomeDoxazosin

Citations

383

FWCI

25.60

field-weighted impact

References

Percentile

100%

vs. same field & year

Citations per year

Cited by

EAU Guidelines on the Treatment and Follow-up of Non-neurogenic Male Lower Urinary Tract Symptoms Including Benign Prostatic Obstruction